Mark A. Hlatky, MD
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3632.
Corresponding Author: Mark A. Hlatky, MD, Stanford University School of Medicine, HRP Redwood Building, Room T150, Stanford, CA 94305; e-mail, email@example.com.
Hlatky MA. A Pound of Prevention? Assessing the Value of New Cholesterol-Lowering Drugs. Ann Intern Med. 2019;170:264–265. [Epub ahead of print 1 January 2019]. doi: https://doi.org/10.7326/M18-3632
Download citation file:
Published: Ann Intern Med. 2019;170(4):264-265.
Published at www.annals.org on 1 January 2019
Cardiology, Coronary Risk Factors, Dyslipidemia.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use